Abbott Laboratories
ABT,
said that a Food and Drug Administration panel voted in favor of the safety profile of its heart device TriClip.
The medical device company on Tuesday said that the Circulatory System Devices Panel of the Medical Devices Advisory Committee also confirmed the effectiveness and risk/benefit profile of the device to treat people with tricuspid regurgitation.
Tricuspid regurgitation is a type of heart valve disease that occurs when the tricuspid valve doesn’t close tight enough.





Founders Fund, a venture capital (VC) firm founded by the billionaire Peter Thiel, is believed to have acquired bitcoin and ethereum worth $200 million sometime in the second half of 2023. The VC firm reportedly began purchasing bitcoin when its price was still under $30,000. Founders Fund’s Renewed Interest in Crypto In the latter half […]




